Pregabalin for Chronic Pruritus – Therapeutic Cheat Sheet
by Azam Qureshi, MD on
Chronic pruritus affects 8-16% of the general population and has a profound impact on patient quality of life.1-3Although the symptom of pruritus may originate from a number of underlying etiologies, including metabolic derangements and infectious causes, along with neoplastic, inflammatory, or psychiatric conditions, other cases may be idiopathic in nature.4 Given the diversity of underlying cont …
Naltrexone for Pruritus – Therapeutic Cheat Sheet
Naltrexone for pruritus
by Adrianna Gonzalez Lopez, MD on
Pruritus, whether related to inflammatory skin conditions or systemic disease, can be debilitating for patients. In order to improve quality of life for patients suffering from severe pruritus, dermatologists often resort to off-label use of systemic medications. In this month’s installment of our Therapeutic Cheat Sheet Series, we will discuss use of naltrexone for treatment of pruritus. Naltr …
Gabapentin for Itch – Therapeutic Cheat Sheet
Gabapentin for itch
by Blair Allais, MD on
Gabapentin is a well-established treatment option for itch with a reassuring safety profile that does not require continued lab monitoring. Generalized itching is a common cause of visits to the dermatologist and can be difficult to treat, leading to sleepless nights and inability to function. We continue our series, Therapeutic Cheat Sheet, with a closer look at gabapentin. GABAPENTIN THERAPEUT …
Terbinafine Therapeutic Cheat Sheet
terbinafine
by Adrianna Gonzalez Lopez, MD on
Dermatophyte infections are estimated to affect about 25% of the world’s population, representing some of the most common infections in the world. Conditions such as onychomycosis and tinea capitis may significantly impact quality of life by way of their symptoms or appearance, making adequate treatment important. Oral and topical formulations of terbinafine are commonly used on- and off-label f …
Dupilumab Therapeutic Cheat Sheet
Dupilumab
by Azam Qureshi, MD on
Atopic dermatitis (AD) is a common skin condition characterized by pruritus and occurs as a result of factors related to impaired skin barrier and immune response, as well as environmental and infectious agents. Patients with poor control on topical therapy are looking for safe and effective systemic treatments. We continue our series, Therapeutic Cheat Sheet, with a closer look at dupilumab, whic …